Carecorp Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 30 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.00 M
- Revenue Growth 5.82%
- Profit Growth -25.00%
- Ebitda -49.54%
- Net Worth 45.29%
- Total Assets 15.41%
About Carecorp Biotech
Carecorp Biotech Private Limited (CBPL) is a Private Limited Indian Non-Government Company incorporated in India on 24 January 2017 (Eight years 30 days old ). Its registered office is in Patna, Bihar, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.00 M.
Himanshu Shekhar, Tarkeshwar Singh, and Rajeshwar Singh serve as directors at the Company.
Company Details
- Location
Patna, Bihar, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999BR2017PTC033393
- Company No.
033393
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Jan 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Patna
Industry
Who are the key members and board of directors at Carecorp Biotech?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Himanshu Shekhar  | Director | 24-Jan-2017 | Current |
| Tarkeshwar Singh | Director | 24-Jan-2017 | Current |
| Rajeshwar Singh | Director | 24-Jan-2017 | Current |
Financial Performance of Carecorp Biotech.
Carecorp Biotech Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 5.82% increase. The company also saw a substantial fall in profitability, with a 25% decrease in profit. The company's net worth Soared by an impressive increase of 45.29%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Carecorp Biotech?
Unlock access to Carecorp Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹1.00 M
₹0
Charges Breakdown by Lending Institutions
- Idbi Bank Limited : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Jan 2023 | Idbi Bank Limited | ₹1.00 M | Open |
How Many Employees Work at Carecorp Biotech?
Unlock and access historical data on people associated with Carecorp Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Carecorp Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Carecorp Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.